Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (291-300 of 522) with videos related to

Pageof 53
Sort By:
The Journal of Urology|October 15, 2019
Reply by AuthorsShweta Dambal, Lauren E Howard, Emma H Allott, et al.
Cancer|December 28, 2016
Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancerZachary Klaassen, Lauren E Howard, Amanda de Hoedt, et al.
The Journal of Urology|June 30, 2016
Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance CandidacyMichael S Leapman, Stephen J Freedland, William J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 19, 2020
Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCHFarnoosh Nik-Ahd, Lauren E Howard, William J Aronson, et al.
Urology|August 20, 2022
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate TissueCiro Andolfi, Andrew J Vickers, Matthew R Cooperberg, et al.
Journal of General Internal Medicine|July 28, 2025
Smarter Screening and Treatment (S3T): Mitigating Harm via Age- and Prostate-Specific Antigen-Stratified ScreeningJames Nie, Nynikka R Palmer, Rena J Pasick, et al.
European Journal of Epidemiology|October 26, 2022
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formulaLouisa H Smith, Xabier García-Albéniz, June M Chan, et al.
The Journal of Urology|April 4, 2020
Competing Risks of Mortality among Men with Biochemical Recurrence after Radical ProstatectomyTimothy J Daskivich, Lauren E Howard, Christopher L Amling, et al.
The Journal of Urology|August 21, 2019
Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH DatabaseShweta Dambal, Lauren E Howard, Emma H Allott, et al.
Prostate Cancer and Prostatic Diseases|May 1, 2019
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancerDrew Moghanaki, Lauren E Howard, Amanda De Hoedt, et al.
Pageof 53

Showing results (291-300 of 522) with videos related to

Sort By:
Pageof 53
The Journal of Urology|October 15, 2019
Reply by AuthorsShweta Dambal, Lauren E Howard, Emma H Allott, et al.
Cancer|December 28, 2016
Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancerZachary Klaassen, Lauren E Howard, Amanda de Hoedt, et al.
The Journal of Urology|June 30, 2016
Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance CandidacyMichael S Leapman, Stephen J Freedland, William J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 19, 2020
Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCHFarnoosh Nik-Ahd, Lauren E Howard, William J Aronson, et al.
Urology|August 20, 2022
Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate TissueCiro Andolfi, Andrew J Vickers, Matthew R Cooperberg, et al.
Journal of General Internal Medicine|July 28, 2025
Smarter Screening and Treatment (S3T): Mitigating Harm via Age- and Prostate-Specific Antigen-Stratified ScreeningJames Nie, Nynikka R Palmer, Rena J Pasick, et al.
European Journal of Epidemiology|October 26, 2022
Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formulaLouisa H Smith, Xabier García-Albéniz, June M Chan, et al.
The Journal of Urology|April 4, 2020
Competing Risks of Mortality among Men with Biochemical Recurrence after Radical ProstatectomyTimothy J Daskivich, Lauren E Howard, Christopher L Amling, et al.
The Journal of Urology|August 21, 2019
Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH DatabaseShweta Dambal, Lauren E Howard, Emma H Allott, et al.
Prostate Cancer and Prostatic Diseases|May 1, 2019
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancerDrew Moghanaki, Lauren E Howard, Amanda De Hoedt, et al.
Pageof 53